Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant ’ s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our common stock is listed on the NASDAQ Capital Market under the trading symbol “DJCO”.
The following table sets forth the sales prices of the Company’s common stock for the periods indicated. Quotations are as reported by the NASDAQ Capital Market.
High
Low
Fiscal year 2025
Quarter ended December 31, 2024
$
602.00
$
463.00
Quarter ended March 31, 2025
596.60
370.00
Quarter ended June 30, 2025
447.02
359.34
Quarter ended September 30, 2025
502.30
384.02
Fiscal year 2024
Quarter ended December 31, 2023
$
357.34
$
286.05
Quarter ended March 31, 2024
402.95
309.22
Quarter ended June 30, 2024
394.50
333.29
Quarter ended September 30, 2024
512.49
387.00
Stockholders
As of December 16, 2025, there were approximately 266 holders of record of the Company’s common stock, and the last trade was at $519.51 per share.
Additional information called for by this item is incorporated herein by reference to the following sections of this Report: Note 7 “ Stock-Based Compensation ” of the Notes to Consolidated Financial Statements included in Item 8; and Item 12 “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”
Dividend Policy
The Company did not declare or pay any dividends during fiscal years 2025 or 2024. A determination by the Company whether or not to pay dividends in the future will depend on numerous factors, including the Company’s earnings, cash flow, financial condition, capital requirements, future prospects, acquisition opportunities, and other relevant factors. The Board of Directors does not expect that the Company will pay any dividends or other distributions to shareholders in the foreseeable future.
Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
From time to time, the Company has repurchased shares of its common stock and may do so in the future. The Company maintains a common stock repurchase program that was implemented in 1987 in combination with the Company’s Management Incentive Plan. See Note 2 of Notes to Consolidated Financial Statements for more information. The Company’s stock repurchase program remains in effect, but the Company did not repurchase any shares during fiscal years 2025 and 2024.
Item 6. [Reserved]
17
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the is authoritative for anything you rely on.